Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa

被引:34
作者
Genter, MB
Burman, DM
Vijayakumar, S
Ebert, CL
Aronow, BJ
机构
[1] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Columbia Univ, Dept Med, New York, NY 10032 USA
[3] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
关键词
gene expression; carcinogenesis; beta-catenin;
D O I
10.1152/physiolgenomics.00120.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alachlor induces olfactory mucosal tumors in rats in a highly ordered temporal process. We used GeneChip analysis to test the hypothesis that histological progression and oncogenic transformation are accompanied by gene expression changes that might yield clues as to the molecular pathogenesis of tumor formation. Acute alachlor exposure caused upregulation of matrix metalloproteinases (MMP)-2 and -9, tissue inhibitor of metalloproteinase-1, carboxypeptidase Z, and other genes related to extracellular matrix homeostasis. Heme oxygenase was upregulated acutely and maintained elevated expression. Expression of ebnerin, related to the putative human tumor suppressor gene DMBT1, progressively increased in alachlor-treated olfactory mucosa. Progression from adenomas to adenocarcinoma was correlated with upregulation of genes in the wnt signaling pathway. Activated wnt signaling was confirmed by immunohistochemical localization of beta-catenin to nuclei of adenocarcinomas, but not earlier lesions. These observations suggest that initiation and progression of alachlor-induced olfactory mucosal tumors is associated with alterations in extracellular matrix components, induction of oxidative stress, upregulation of ebnerin, and final transformation to a malignant state by wnt pathway activation.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 84 条
[11]   Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon [J].
Burnouf, DY ;
Miturski, R ;
Nagao, M ;
Nakagama, H ;
Nothisen, M ;
Wagner, J ;
Fuchs, RPP .
CARCINOGENESIS, 2001, 22 (02) :329-335
[12]   Transcriptional regulation and function during the human cell cycle [J].
Cho, RJ ;
Huang, MX ;
Campbell, MJ ;
Dong, HL ;
Steinmetz, L ;
Sapinoso, L ;
Hampton, G ;
Elledge, SJ ;
Davis, RW ;
Lockhart, DJ .
NATURE GENETICS, 2001, 27 (01) :48-54
[13]   CONSTITUTIVE EXPRESSION OF METALLOTHIONEIN GENES IN MOUSE-BRAIN [J].
CHOUDHURI, S ;
KRAMER, KK ;
BERMAN, NEJ ;
DALTON, TP ;
ANDREWS, GK ;
KLAASSEN, CD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 131 (01) :144-154
[14]   Occurrence and load of selected herbicides and metabolites in the lower Mississippi River [J].
Clark, GM ;
Goolsby, DA .
SCIENCE OF THE TOTAL ENVIRONMENT, 2000, 248 (2-3) :101-113
[15]   In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms [J].
Coleman, S ;
Liu, SM ;
Linderman, R ;
Hodgson, E ;
Rose, RL .
CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 122 (01) :27-39
[16]   The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors [J].
Crawford, HC ;
Fingleton, BM ;
Rudolph-Owen, LA ;
Goss, KJH ;
Rubinfeld, B ;
Polakis, P ;
Matrisian, LM .
ONCOGENE, 1999, 18 (18) :2883-2891
[17]  
Croce Maria V., 2001, Pathology and Oncology Research, V7, P284
[18]   Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression:: Correlation with invasive growth of breast cancer [J].
Dalberg, K ;
Eriksson, E ;
Enberg, U ;
Kjellman, M ;
Bäckdahl, M .
WORLD JOURNAL OF SURGERY, 2000, 24 (03) :334-340
[19]   TEMPORALSPATIAL PATTERNS OF EXPRESSION OF METALLOTHIONEIN-I AND METALLOTHIONEIN-III AND OTHER STRESS-RELATED GENES IN RAT-BRAIN AFTER KAINIC ACID-INDUCED SEIZURES [J].
DALTON, T ;
PAZDERNIK, TL ;
WAGNER, J ;
SAMSON, F ;
ANDREWS, GK .
NEUROCHEMISTRY INTERNATIONAL, 1995, 27 (01) :59-71
[20]   Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the β-catenin pathway [J].
Danilkovitch-Miagkova, A ;
Miagkov, A ;
Skeel, A ;
Nakaigawa, N ;
Zbar, B ;
Leonard, EJ .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) :5857-5868